Blue Pool Capital

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers payment solutions for online purchases. It operates a platform that provides customers in the UAE and Saudi Arabia with a buy now, pay later option, allowing them to make payments for their purchases either in a single deferred payment or through multiple installments. This service aims to enhance financial flexibility, enabling consumers to manage their spending more effectively while ensuring safe payment transactions. Through its innovative approach, Tabby seeks to reshape the relationship individuals have with their finances, promoting a more accessible shopping experience.

Cambium Carbon is an early-stage social enterprise focused on addressing climate change through reforestation and urban wood reuse. The company collaborates with cities and various partners to divert fallen city trees from landfills, transforming them into valuable resources. By establishing reforestation hubs, Cambium Carbon creates a circular economy that reclaims urban wood waste and generates revenue. This revenue is then invested in planting and maintaining trees, supporting city planners in creating sustainable jobs and fostering resilient urban environments. Through these initiatives, Cambium Carbon aims to implement effective natural climate solutions while promoting local regenerative wood supply chains.

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers payment solutions for online purchases. It operates a platform that provides customers in the UAE and Saudi Arabia with a buy now, pay later option, allowing them to make payments for their purchases either in a single deferred payment or through multiple installments. This service aims to enhance financial flexibility, enabling consumers to manage their spending more effectively while ensuring safe payment transactions. Through its innovative approach, Tabby seeks to reshape the relationship individuals have with their finances, promoting a more accessible shopping experience.

GetYourGuide operates an online platform that allows users to book tours, attractions, and activities globally. Founded in June 2009 by Jochen Mattes, Johannes Reck, Martin Sieber, Pascal Mathis, Tao Tao, and Tobias Rein, the company acts as a mediator between customers and service providers, facilitating the booking of experiences such as cooking classes and skip-the-line tickets for popular tourist sites. The platform is accessible via the internet and mobile applications, providing a variety of options for travelers, including last-minute activities and guided tours. While the service is free for customers, providers pay GetYourGuide a percentage of their revenue for each booking. An integrated customer review system helps users assess the quality of tour providers, with the platform actively removing those that consistently receive poor reviews.

Artifact Labs is a leading Web3 and NFT company.

Premier Lacrosse League (PLL) operates a professional lacrosse league in North America, showcasing top talent in the sport. By adopting a tour-based model, the league aims to elevate lacrosse to a national stage, providing fans with engaging entertainment. In addition to organizing tournaments, PLL also sells sports-related apparel online, further enhancing its connection with fans and promoting the growth of lacrosse. Through its innovative approach, PLL seeks to pioneer a new future for the sport, making it more accessible and enjoyable for a broader audience.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Aver is a decentralized peer-to-peer betting exchange built on the Solana blockchain and the world’s first decentralized Web3 betting exchange.

Artemis is a decentralized mobile-focused NFT social and trading platform.

Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security, and new business models.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

FogPharma is a biotechnology company focused on developing innovative cancer therapies through its unique cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, the company aims to address cancer-causing proteins that are typically inaccessible to traditional treatments. By collaborating with leading experts in cancer biology and therapy, FogPharma is creating a new class of medicines designed to neutralize these challenging targets. The company is supported by a diverse group of private and institutional investors, which enables it to pursue its mission of delivering transformative cancer treatments. FogPharma is dedicated to improving the lives of patients and their families, striving to extend both life expectancy and quality of life.

Brii Biosciences Limited is a biotechnology company focused on the research, development, and commercialization of medicines for chronic illnesses, particularly infectious diseases, liver, and lung conditions. Founded in 2018, the company operates from Durham, North Carolina, with additional offices in Shanghai, Beijing, and San Francisco. Brii Biosciences aims to provide innovative biopharmaceutical solutions tailored to the needs of Chinese patients, addressing public health challenges such as hepatitis B, HIV, and multidrug-resistant infections. The company leverages technology and data to enhance the Chinese healthcare system, ensuring better access to effective treatments. With a diverse pipeline of over ten product candidates, Brii Biosciences is committed to improving health outcomes for patients suffering from both infectious and central nervous system diseases.

FogPharma is a biotechnology company focused on developing innovative cancer therapies through its unique cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, the company aims to address cancer-causing proteins that are typically inaccessible to traditional treatments. By collaborating with leading experts in cancer biology and therapy, FogPharma is creating a new class of medicines designed to neutralize these challenging targets. The company is supported by a diverse group of private and institutional investors, which enables it to pursue its mission of delivering transformative cancer treatments. FogPharma is dedicated to improving the lives of patients and their families, striving to extend both life expectancy and quality of life.

Hua Medicine is a clinical-stage drug development company based in Pudong, China, specializing in innovative therapies for diabetes and central nervous system (CNS) disorders. Founded in 2009 by experienced professionals in the pharmaceutical industry, the company is advancing its lead product, Dorzagliatin, an oral medication for Type 2 diabetes, which has reached the NDA enabling stage and is currently undergoing two Phase 3 trials in drug-naive and metformin-treated patients in China. Additionally, Hua Medicine is exploring mGLUR5, a novel drug candidate aimed at treating levodopa-induced dyskinesia in Parkinson's disease. The company has secured funding from prominent international venture capital firms and has in-licensed global rights to its diabetes drug, positioning itself as a key player in the treatment landscape for these chronic conditions.

Rent the Runway, Inc. is an e-commerce platform that allows women to rent designer apparel and accessories, offering a transformative approach to fashion consumption. Founded in 2008 and based in New York, the company provides a range of options including party dresses, gowns, jumpsuits, outerwear, and accessories such as jewelry and handbags. Rent the Runway operates both an online platform and physical stores in locations like New York City, San Francisco, Santa Monica, and Washington, D.C. Through its subscription model, users can access an extensive collection of clothing for various occasions, while also having the option to rent items a-la-carte or purchase them outright. The company emphasizes sustainability and empowerment, catering to modern women's needs in a rapidly evolving fashion landscape.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Lytro, founded in 2006 by Ren Ng, is a pioneer in Light Field imaging technology, which allows for the capture of multi-dimensional data and enhances creative freedom for artists and innovators. The company launched its first consumer Light Field camera in 2012, followed by the second-generation platform in 2014 that included the Lytro ILLUM, Lytro Desktop, and mobile applications. This technology has applications beyond photography, extending into cinematography, virtual reality, and scientific fields. Lytro aims to be a central hub in a new technology ecosystem, providing tools that empower users to explore and utilize Light Field imaging to its fullest potential. Headquartered in Mountain View, California, Lytro has garnered support from prominent venture capital firms, reinforcing its role as a leader in computational imaging.

Fanatics, Inc. is a prominent global sports merchandise company that designs, manufactures, and distributes licensed sports apparel and fan gear. Founded in 1995 and headquartered in Jacksonville, Florida, the company operates through various retail channels, including online, mobile, and physical stores. Fanatics serves a diverse range of customers, including professional sports leagues, collegiate teams, and media brands, effectively meeting the dynamic expectations of sports fans in today's mobile-first, on-demand market. With additional offices in California and the United Kingdom, Fanatics has established itself as a key player in the sports e-commerce sector, continuously enhancing its offerings to cater to the needs of fans and retailers alike.